Out of all the different approaches available to find new therapies to treat COVID-19, drug repurposing is one of the fastest and safest methods, as the drugs are already being used to treat other conditions therefore leading to fewer chances of adverse reactions. In particular, artificial intelligence (AI) holds significant promise for biopharmaceutical companies to expedite the drug repurposing process, says GlobalData, a leading data and analytics company.
